Cutting-Edge Nanomedicine Advancements in Cancer Disease
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 10 August 2025 | Viewed by 60
Special Issue Editors
Interests: breast cancer; chemotherapy; drug delivery; drug targeting; gynecological cancers; microparticles; nanocarriers; nanomedicine; nanotheranostics
Special Issues, Collections and Topics in MDPI journals
Interests: antimicrobial agents; breast cancer; cannabinoids; drug delivery; drug targeting; in situ-forming implants; nanomedicine; ovarian cancer; polymers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has revolutionized the treatment of numerous diseases, offering innovative solutions for targeted therapies, early diagnosis, and precision medicine. Among these applications, cancer stands out as one of the fields where nanotechnology holds the greatest promise. Traditional cancer treatments face significant limitations, such as unspecific biodistribution, off-target toxicity, low aqueous solubility, the inability to effectively distinguish between healthy and cancerous tissues, and drug resistances. Nanomedicines, however, provide advanced solutions that can overcome these challenges by enabling more precise and controlled drug delivery, minimizing systemic toxicity, and improving therapeutic outcomes.
This Special Issue seeks to gather cutting-edge research focused on the application of nanomedicine in treating and diagnosing cancer. We invite original research and review articles from interdisciplinary fields such as nanotechnology, oncology, molecular imaging, pharmaceutical sciences, and beyond. Contributions should focus on advancing knowledge in nanomedicine and its role in revolutionizing cancer management. We are particularly interested, but not limited to, studies that explore the following topics:
- Nanoparticle-based delivery systems for anticancer drugs.
- Nanoparticle-based immunotherapy.
- Nanoprobes for improved cancer imaging and early cancer detection.
- Active targeting nanoformulations for precision medicine.
The safety and clinical translation of nanomedicines.
Prof. Dr. Ana Isabel Torres-Suárez
Dr. Ana Isabel Fraguas-Sánchez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- active targeting
- breast cancer
- drug delivery
- liposomes
- lung cancer
- metallic nanoparticles
- polymeric nanoparticles
- theragnostic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
